https://orcid.org/0000-0002-9574-6037
References
- Aceto N, Sausgruber N, Brinkhaus H, et al. (2012). Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop. Nat Med 18:529–37.
- Ali M, Daze KD, Strongin DE, et al. (2015). Molecular insights into inhibition of the methylated histone-plant homeodomain complexes by calixarenes. J Biol Chem 290:22919–30.
- Astorgues-Xerri L, Riveiro ME, Tijeras-Raballand A, et al. (2014). OTX008, a selective small-molecule inhibitor of galectin-1, downregulates cancer cell proliferation, invasion and tumor angiogenesis. Eur J Cancer 50:2463–77.
- Bhattacharyya S, Mandal D, Sen GS, et al. (2007). Tumor-induced oxidative stress perturbs nuclear factor-kappaB activity-augmenting tumor necrosis factor-alpha-mediated T-cell death: protection by curcumin. Cancer Res 67:362–70.
- Collina F, Di Bonito M, Li Bergolis V, et al. (2015). Prognostic value of cancer stem cells markers in triple-negative breast cancer. Biomed Res Int 2015:158682.
- Dey N, Barwick BG, Moreno CS, et al. (2013). Wnt signaling in triple negative breast cancer is associated with metastasis. BMC Cancer 13:537.
- Dondoni A, Marra A, Scherrmann MC, et al. (1997). Synthesis and properties of O-glycosyl calix[4]arenes (calixsugars). Chem Eur J 3:1774–82.
- Donmez HG, Demirezen S, Beksac MS. (2016). The relationship between beta-catenin and apoptosis: a cytological and immunocytochemical examination. Tissue Cell 48:160–7.
- Gogoi B, Sen Sarma N. (2015). Curcumin-cysteine and curcumin tryptophan conjugate as fluorescence turn on sensors for picric acid in aqueous media. Acs Appl Mater Interfaces 7:11195–202.
- He LL, Gu J, Lim LY, et al. (2016). Nanomedicine-mediated therapies to target breast cancer stem cells. Front Pharmacol 7(65103).
- Mo J, Eggers PK, Chen X, et al. (2015). Shear induced carboplatin binding within the cavity of a phospholipid mimic for increased anticancer efficacy. Sci Rep 5:10414.
- Mo J, Eggers PK, Yuan ZX, et al. (2016). Paclitaxel-loaded phosphonated calixarene nanovesicles as a modular drug delivery platform. Sci Rep 6:23489.
- Pakula H, Xiang D, Li Z. (2017). A tale of two signals: AR and WNT in development and tumorigenesis of prostate and mammary gland. Cancers 9:14.
- Panda AK, Chakraborty D, Sarkar I, et al. (2017). New insights into therapeutic activity and anticancer properties of curcumin. J Pharmacol Exp Ther 9:31–45.
- Proverbs-Singh T, Feldman JL, Morris MJ, et al. (2015). Targeting the androgen receptor in prostate and breast cancer: several new agents in development. Endocr Relat Cancer 22:R87–106.
- Reya T, Morrison SJ, Clarke MF, Weissman IL. (2001). Stem cells, cancer, and cancer stem cells. Nature 414:105–11.
- Shi S, Han L, Gong T, et al. (2013). Systemic delivery of microRNA-34a for cancer stem cell therapy. Angew Chem Int Ed Engl 52:3901–5
- Thakkar A, Wang B, Picon-Ruiz M, et al. (2016). Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer. Breast Cancer Res Treat 157:77–90.